Shanti Gold International Limited announced the results of its postal ballot conducted on April 23, 2026. Shareholders approved the re-appointment and remuneration increase for Managing Director Mr. Pankajkumar Jagawat and Whole-Time Director Mr. Manojkumar Jain with over 99.98% majority. The results confirm strong shareholder support for the current leadership and their revised compensation terms.
SEBI issued an administrative warning to Manappuram Finance Ltd's Chairman, Mr. V.P. Nandakumar, for a 7-day delay in disclosing share encumbrances in 2018. The company stated this has no financial impact as it was issued in his personal capacity.
RBL Bank Limited reported its audited financial results for FY26, recommending a dividend of ₹1 per equity share (10%). Standalone net profit for the year ended March 31, 2026, stood at ₹822.44 Crore. The bank also updated on a pending regulatory approval for Emirates NBD Bank to acquire up to 74% stake.
RBL Bank Limited reported its audited financial results for FY26, recommending a dividend of ₹1 per equity share (10%). Standalone net profit for the year ended March 31, 2026, stood at ₹822.44 Crore. The bank also updated on a pending regulatory approval for Emirates NBD Bank to acquire up to 74% stake.
SRU Steels Ltd's Board will meet on April 29, 2026, to approve a Postal Ballot for member approval of M/S BMGS & Associates' appointment as Statutory Auditor. The meeting will also appoint a scrutinizer and decide the cut-off date for voting eligibility.
Polycab India Limited incorporated a wholly-owned subsidiary, Polycon Infra Projects Private Limited (PIPPL), on April 24, 2026. PIPPL has an authorized capital of ₹1.00 Crore and will focus on EPC projects in the power and telecom sectors. Polycab holds 100% of the initial 1,00,000 equity shares subscribed at face value.
Carysil is scaling global operations in kitchen sinks and appliances, targeting ₹300 Cr capex to accelerate growth through FY30 with a focus on premium segments.
Aeron Composite Limited informed the exchange that it does not qualify as a 'Large Corporate' under SEBI norms for FY 2026-27. The company does not meet the specified outstanding borrowing or credit rating thresholds. Consequently, the initial disclosure requirements under the SEBI circular are not applicable to the entity.
Accord Synergy Limited has scheduled a Board Meeting for May 4, 2026. The primary agenda is to consider and approve the audited standalone financial results for the year ended March 31, 2026.
Nila Infrastructures Ltd received an order from the IT Appellate Authority regarding its AY 2018-19 assessment. The authority partly allowed the company's appeal, restricting the income addition to ₹33.23 lac. The company stated there is no impact on operations and will seek legal consultation for further action.
Star Delta Transformers Ltd clarified to BSE that recent share price and volume movements are purely market-driven. The company confirmed it has made all required disclosures under SEBI Regulation 30 and is not withholding any price-sensitive information. The management stated they are not connected to the current market fluctuations.
Ravi Kumar Distilleries Limited confirmed it is not classified as a 'Large Corporate' as of March 31, 2026, under SEBI's framework. The company reported outstanding long-term borrowings of ₹0.98 Crore, remaining below the mandatory debt-issuance threshold for large entities.
Axis Bank Ltd reported a standalone net profit of ₹7,071 Crore for Q4FY26, up 9% QoQ. The bank achieved healthy loan growth of 19% YoY and maintained stable asset quality with GNPA at 1.23%. Net Interest Income grew 5% YoY, supported by a Net Interest Margin of 3.62%.
Axis Bank Ltd reported a standalone net profit of ₹7,071 Crore for Q4FY26, up 9% QoQ. The bank achieved healthy loan growth of 19% YoY and maintained stable asset quality with GNPA at 1.23%. Net Interest Income grew 5% YoY, supported by a Net Interest Margin of 3.62%.
Zydus Lifesciences received DCGI approval to initiate Phase III clinical trials for Zintrodiazine, a novel anti-malarial candidate. Two trials involving 651 and 390 patients will evaluate efficacy against P. falciparum and P. vivax malaria in India. This marks a significant milestone in developing alternatives to current artemisinin-based therapies facing resistance.
Krishival Foods Limited has scheduled a Board Meeting on May 4, 2026. The board will consider auditing financial results for FY2026, recommending a final dividend, and approving employee stock option grants. Trading window for designated persons is closed from April 1, 2026, until 48 hours after the results declaration.
SRG Housing Finance Limited has issued a Postal Ballot notice to shareholders. The company seeks approval via special resolutions to increase borrowing limits under Section 180(1)(c) and create charges on assets under Section 180(1)(a) of the Companies Act, 2013. The e-voting period ends on May 28, 2026.
Axis Bank's board recommended a Rs. 1 per share dividend and approved massive fund-raising plans totaling ₹55,000 Crore. This includes ₹35,000 Crore through debt instruments and ₹20,000 Crore via equity or other convertible securities to strengthen capital reserves and support growth.
India Ratings and Research has affirmed Rashtriya Chemicals and Fertilizers Limited's credit rating for its ₹1200 Crore Non-Convertible Debentures at 'IND AA' with a Stable outlook. The affirmation reflects RCF's strong market position and strategic importance to the government.
Kshitij Polyline Limited has appointed M/s. Valavat & Associates as Internal Auditors for a 12-month term, effective April 24, 2026. The firm brings extensive experience across diverse sectors including NBFC, banking, and technology. This appointment was approved during the Board Meeting held on April 24, 2026.
Current Infraprojects Limited has declared that filing quarterly Corporate Governance Reports is not applicable for the quarter ended March 31, 2026. The company is exempt under Regulation 15 of SEBI LODR as it is listed on the NSE SME Exchange and falls below the prescribed capital and net worth thresholds.
Axis Bank Limited reported its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The Board recommended a dividend of ₹1 per share (50%). The results, audited with an unmodified opinion, show a standalone net profit of ₹24,456.66 Crore for the full financial year.
Axis Bank Limited reported its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The Board recommended a dividend of ₹1 per share (50%). The results, audited with an unmodified opinion, show a standalone net profit of ₹24,456.66 Crore for the full financial year.
Gretex Industries Limited informed the exchange regarding the non-applicability of Regulation 24A (Secretarial Compliance Report) and Corporate Governance provisions. The company is exempt under Regulation 15 of SEBI LODR as its equity shares are listed on the NSE Emerge platform.
RACL Geartech Limited confirmed it does not qualify as a 'Large Corporate' for FY 2025-26 under SEBI norms. As of March 31, 2026, the company's outstanding long-term borrowings remained below the ₹100 crore threshold. This disclosure exempts the company from specific incremental debt-raising requirements mandated by SEBI for large entities.
Shree Securities Ltd's board approved the voluntary delisting of equity shares from the Calcutta Stock Exchange Limited. The company will remain listed on the BSE, meaning no exit opportunity is required for shareholders. The decision was formalized during a board meeting held on April 25, 2026.
JD Cables Ltd reported a 45% YoY revenue growth for FY26, reaching ₹36,459.15 Crore. The company invested ₹17.68 Crore in capacity expansion at its new Dankuni facility. Management aims to evolve into an integrated EPC player, supported by a ₹515 Crore order book and improved capacity utilization across units.
Pasupati Acrylon Limited confirmed its non-applicability under the SEBI 'Large Corporate Framework' for the financial year ended March 31, 2026. The company does not meet the criteria specified in SEBI circulars, exempting it from certain debt-raising disclosure requirements.
SPL Industries Ltd clarified to BSE that the recent significant movement in its share price is purely market-driven. The company confirmed it is in compliance with SEBI Regulation 30 and that no undisclosed material information or events exist that could impact the price behavior of its scrip.
Alembic Pharmaceuticals received USFDA final approval for Fingolimod Capsules, 0.5 mg, used for treating relapsing forms of multiple sclerosis. The product has an estimated annual market size of approximately ₹1363.0 Crore (US$ 145 million). This marks the company's 237th cumulative ANDA approval, strengthening its US generic portfolio.
